Young Survival Coalition Hosts Summit for BC Survivors, Supporters
More than 600 young breast cancer survivors will gather in Austin, Texas, for the 4th Annual Young Survival Coalition (YSC) Summit. For such survivors, ... Read more
Updates
-
News Young Survival Coalition Hosts Summit for BC Survivors, Supporters
-
News Experimental Compound Could Broaden HER2-targeted Approach to BC
-
News Changes in Gene Expression May Hint at Relapse Risk in ER-positive Patients on Hormone Therapy, Study Finds
-
A Lump in the Road - A Column by Nancy Brier, Columns The Luck of the Draw
-
News Margetuximab Helps to Delay Disease Progression in Advanced, HER2-positive Breast Cancers, Phase 3 Trial Shows
-
News FDA to Review Kadcyla for Certain HER2-positive Early-stage Breast Cancer Patients
-
News Knight Therapeutics Acquires Exclusive Marketing Rights to Nerlynx in Canada
-
News Breast Cancers Diagnosed Within 10 Years of Pregnancy Have Higher Risk of Metastasis, Study Shows
-
News Blocking Interaction Between Blood Vessels, Cancer Cells Could Prevent Disease’s Spread, Study Says
-
News Mathematical Model Calculates Breast Cancer Risk in Women
-
A Lump in the Road - A Column by Nancy Brier, Columns Teaching an Old Drug New Tricks: Ketamine and Depression
-
News Breast Cancer Cells Can Be Turned into Harmless Fat Cells in Mice, Study Shows
-
News FDA Wants More Data Before Sacituzumab Govitecan Is Approved for Metastatic Triple-negative Breast Cancer
-
News Tinagl1 Protein Suppresses Triple-negative Breast Cancer Development in Mouse Study
-
News Phase 3 Trial of Oraxol for Metastatic Breast Cancer Is Fully Enrolled
-
News Insight Into How Breast Cancers Evade Immune System Could Help in Developing Therapies, Study Says
-
News Breast Cancer Risk Appears to Be Higher in Women Who Have Had Babies, Study Shows
-
News Phase 1b/2 Trial Testing Rebastinib/Chemo Combo in Advanced Cancer Patients Begins
-
News Partial Breast Radiation Therapy May Effectively Prevent Cancer Relapse, Trial Shows
-
News FDA OKs Phase 2 Trial of AE37-Keytruda Combo in Metastatic Triple-negative Breast Cancer
-
A Lump in the Road - A Column by Nancy Brier, Columns Short, Striped, and Revealing: The Worst New Year’s Eve Dress Ever
-
News Circulating Tumor Cell Numbers May Help Decide Best Therapy for Metastatic Breast Cancer, Phase 3 Trial Shows
-
News Phase 3 Trial of Sacituzumab Govitecan Recruiting Triple-negative Breast Cancer Patients
-
News Study Reveals a Weakness of Breast Cancer Bone Metastasis
-
A Lump in the Road - A Column by Nancy Brier, Columns Breast Cancer Stole My Bling
-
News Enrollment Complete in Phase 2 Trial of NeuVax-Herceptin for HER2-Positive, High-Risk Breast Cancer
-
News Couple Share $1.8 Million to Test More Precise Image-guided Breast Radiation Therapy
-
News Phase 1/2 Trial Testing Combo of Bria-IMT and Immune Checkpoint Inhibitors Begins Dosing Breast Cancer Patients
-
News J. Lohr Vineyards Marks 10 Years of Supporting the National Breast Cancer Foundation
-
A Lump in the Road - A Column by Nancy Brier, Columns Yeah, Doctor. I’m Talking to You
-
News Planned Phase 2 Trial to Test Vaccine in Triple-negative Breast Cancer Patients, Generex Says
-
News 2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment
-
News Tecentriq-Chemo Combo Under FDA Review as First-line Therapy for PD-L1-positive, Metastatic Triple-negative Breast Cancer
-
A Lump in the Road - A Column by Nancy Brier, Columns We May Not Think About It, but Trusting the Process Is Important
-
News DoD Awards $11M for Phase 2 Trial of TPIV110 Breast Cancer Therapy
-
A Lump in the Road - A Column by Nancy Brier, Columns Gary Buys a Sandwich
-
News Early-stage Breast Cancer Patients Failing to Use to Hormone Therapy Long-term, French Study Finds
-
News Researchers Develop ‘Bio-patch’ to Monitor Post-surgical Success of Breast Reconstruction
-
News Phase 2 Trial to Test Keytruda, Tomivosertib Combo in Triple-negative Breast Cancers
-
A Lump in the Road - A Column by Nancy Brier, Columns The Dodgers, the Statue of Liberty, Breast Cancer, and Me
-
News Ibrance-Faslodex Combo Improves Survival of Advanced Breast Cancer Patients, Phase 3 Trial Shows
-
News Processed Meat Consumption Linked to Higher Breast Cancer Risk, Review Study Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns Paint the Parking Spot Pink
-
News Therapies Given to Women with Advanced Breast Cancer Equally Effective and Safe in Men, Studies Report
-
News Tecentriq-Abraxane Prolongs Survival of Advanced Triple-negative Breast Cancer Patients, Study Shows
-
News Sermonix Launches Phase 2 Trial Testing Lasofoxifene in Advanced Breast Cancer Patients with ER Mutations
-
A Lump in the Road - A Column by Nancy Brier, Columns I Wouldn’t Give My Right Arm
-
News University of Cincinnati Institute Opens Breast and Ovarian Cancer Risk Program
-
News FDA Approves Talzenna to Treat BRCA-mutated Metastatic Breast Cancer
-
News ‘Where’s My Mammogram?’ Campaign Encourages Women to Keep Track of Breast Images
-
A Lump in the Road - A Column by Nancy Brier, Columns A Half-empty Glass
-
News First Patient Dosed in Phase 1/2 Trial of FLX475 in Breast, Other Advanced Cancers
-
News Mammography Screening Does Not Reduce Breast Cancer Mortality, Study Suggests
-
News Fluorescent Tracer Can Improve Detection of Breast Tumor Margins During Surgery
-
News Sales of Limited-edition Crocs to Support Susan G. Komen Breast Cancer Organization
-
News Potential Effects of Thousands of Mutations in BRCA1 Gene Analyzed by Researchers
-
A Lump in the Road - A Column by Nancy Brier, Columns Don’t Let $5 Stand in the Way of Your Dreams
-
News Many Women Being Told of Breast Cancer in Phone Chat with Doctor, Study Finds
-
News CrownBio Acquires Patient-derived Breast Cancer Mouse Models from University of Utah
-
A Lump in the Road - A Column by Nancy Brier, Columns Cocktail Hour in the Produce Aisle
-
News First Patient Dosed in Phase 1b Trial Testing Cirmtuzumab Add-on in HER2-negative Breast Cancer Patients
-
News Machine-learning Technique May Speed Identifying ER-positive Breast Cancers
-
News Videssa Blood Test Improves Breast Cancer Detection in Post-menopausal Women, Study Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns Chemo’s Secret Embarrassing Side Effect
-
News Online Test Measures Women’s Risk of Cancer Recurrence or Spread After Hormone Therapy
-
News Breast Cancer Patients in Nursing Homes Experience Worse Mortality Rates, Functional Declines After Surgery, Study Finds
-
A Lump in the Road - A Column by Nancy Brier, Columns Barfing in Public and Other Cancer Stories
-
News Eating Broccoli Sprouts While Pregnant May Help Prevent Breast Cancer in Child Decades Later, Mouse Study Shows
-
News Health Canada Approves Perjeta Combo Therapy for Early Breast Cancer After Surgery
-
News PET Tracer Detects Estrogen Receptor Levels Across Breast Cancer Metastases, Study Finds
-
A Lump in the Road - A Column by Nancy Brier, Columns My Hedge, My Cancer: We’re Both Going to Make It
-
News A Primary Breast Cancer Tumor Can Inhibit Cancer Cells from Forming Secondary Tumors, Mice Study Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns Trading Places with My Husband
-
News Novartis’ BYL719 Improved Patient Survival in Phase 3 Trial of Advanced Breast Cancer
-
News Genome Analysis of DNA from Nigerian Women Leads to 1st African Breast Cancer Risk Prediction Model
-
A Lump in the Road - A Column by Nancy Brier, Columns Your Health, Your Hair, Your Heart: What to Know After a Breast Cancer Diagnosis
-
A Lump in the Road - A Column by Nancy Brier, Columns Now’s Not the Time for Politics
-
News NCI Awards $2.3M Grant to Advance Possible Therapy for Triple-negative Breast Cancer
-
News FDA Approves Non-radioactive Tracer Able to Detect Lymph Nodes Affected by Breast Cancer
-
News Low Levels of Tumor Suppressor Protein May Predict Risk of Breast Cancer Recurrence, Study Says
-
A Lump in the Road - A Column by Nancy Brier, Columns Beating the Odds with Cancer and Fires
-
News Cells Lining the Breast Duct Grab Stray Cancer Cells to Prevent Metastasis, Study Shows
-
News New Technique Can Spot Breast Tumors Other Methods Might Miss
-
News Breast Cancer Patients Still Face Significant Financial Burden, Study Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns Breast Cancer Taught Me the Urgency of Saying ‘Yes’ to Adventure
-
News Eating More Fruits and Vegetables May Reduce Risk of Breast Cancer, Study Suggests
-
News Two New Indications of Kisqali Approved in US for Advanced Breast Cancers
-
News New Map of Cancer Cell’s Genome Shows 1000s of Previously Missed Variations
-
News Regular Stretching Found to Impair Breast Cancer Growth in Mouse Study
-
News Trial Testing Need for Radiotherapy in HER2-Positive Breast Cancer Enrolling Patients
-
News Machine Learning Provides Early Lymphedema Detection in Breast Cancer Survivors, Study Reports
-
News Tecentriq-Abraxane Combo Reduces Risk of Worsening Disease, Death in Metastatic Triple Negative Breast Cancer, Phase 3 Trial Shows
-
News Imfinzi-Chemo Combo Shows Effectiveness in Treating Triple-negative Breast Cancer, Phase 2 Study Shows
-
A Lump in the Road - A Column by Nancy Brier, Columns If Fitness Could Come in a Pill
-
News New Imaging Approach Scans Entire Breast and Finds Tumors in Seconds
-
News Aurora Kinase A Confers Drug Resistance to Breast Cancer Cells, Lab Study Shows
-
News Phase 3 Trial Testing Aromasin-Chidamide Combo for Advanced Breast Cancer Meets Primary Goal
-
A Lump in the Road - A Column by Nancy Brier, Columns Girl Scout Gone Rogue
-
News High Body Fat in Young Women Linked to a Lower Risk of Breast Cancer
-
-
Experimental Compound Could Broaden HER2-targeted Approach to BC
By targeting small regulatory molecules called microRNAs (miRNAs), researchers were able to reprogram breast cancer cells and render them sensitive to HER2-targeting medicines, such as Herceptin (trastuzumab) ... Read more -
Changes in Gene Expression May Hint at Relapse Risk in ER-positive Patients on Hormone Therapy, Study Finds
Specific changes in gene expression might help to predict the risk of relapse in estrogen receptor (ER)-positive breast cancer patients under hormone therapy, ... Read more -
The Luck of the Draw
Through the unlikeliest of circumstances, I found myself in a first-class seat on a flight to Guatemala this week. They actually served warm almonds ... Read more -
Margetuximab Helps to Delay Disease Progression in Advanced, HER2-positive Breast Cancers, Phase 3 Trial Shows
A combination of MacroGenics‘ HER2 antibody margetuximab and standard chemotherapy is superior to Herceptin (trastuzumab) plus chemotherapy at extending the time to disease progression among ... Read more
-
FDA to Review Kadcyla for Certain HER2-positive Early-stage Breast Cancer Patients
The U.S. Food and Drug Administration is reviewing Kadcyla (trastuzumab emtansine) as a post-surgery treatment for ... -
Knight Therapeutics Acquires Exclusive Marketing Rights to Nerlynx in Canada
Breast cancer treatment Nerlynx (neratinib) will be exclusively commercialized in Canada by Knight Therapeutics, under ... -
Breast Cancers Diagnosed Within 10 Years of Pregnancy Have Higher Risk of Metastasis, Study Shows
Women diagnosed with breast cancer up to 10 years after giving birth have a ... -
Blocking Interaction Between Blood Vessels, Cancer Cells Could Prevent Disease’s Spread, Study Says
Blocking the interaction between cancer cells and their microenvironment could be a viable strategy ... -
Mathematical Model Calculates Breast Cancer Risk in Women
Researchers developed a mathematical model to calculate breast cancer risk in women, based on ... -
Teaching an Old Drug New Tricks: Ketamine and Depression
“No fresh flowers,” my doctor said. “Avoid salad. No uncooked food. And don’t bring ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
-
Breast Cancer Cells Can Be Turned into Harmless Fat Cells in Mice, Study Shows
With the right molecular cues, breast cancer cells can be converted into harmless fat ... -
FDA Wants More Data Before Sacituzumab Govitecan Is Approved for Metastatic Triple-negative Breast Cancer
The U.S. Food and Drug Administration (FDA) has rejected Immunomedics’ application for accelerated approval ... -
-
-
-
-
Phase 1b/2 Trial Testing Rebastinib/Chemo Combo in Advanced Cancer Patients Begins
A Phase 1b/2 clinical trial testing rebastinib, in combination with the chemotherapy medication carboplatin, ... -
-
-
-
Circulating Tumor Cell Numbers May Help Decide Best Therapy for Metastatic Breast Cancer, Phase 3 Trial Shows
The number of circulating tumor cells (CTCs) could help doctors choose between hormone therapy ... -
-
-
Study Reveals a Weakness of Breast Cancer Bone Metastasis
A new study analyzing the cross-talk between bone cells and cancer cells in metastatic ... -
Breast Cancer Stole My Bling
I have skinny wrists, so I’ve never gotten into the habit of wearing bracelets. ... -
Enrollment Complete in Phase 2 Trial of NeuVax-Herceptin for HER2-Positive, High-Risk Breast Cancer
The investigator-sponsored trial studying a combination of NeuVax (nelipepimut-S, NPS) and Herceptin (trastuzumab) as a ... -
Couple Share $1.8 Million to Test More Precise Image-guided Breast Radiation Therapy
A new strategy for delivering a higher dose of radiotherapy with increased precision to ... -
Phase 1/2 Trial Testing Combo of Bria-IMT and Immune Checkpoint Inhibitors Begins Dosing Breast Cancer Patients
BriaCell Therapeutics has started patient dosing in a Phase 1/2a clinical trial testing its immunotherapy ... -
J. Lohr Vineyards Marks 10 Years of Supporting the National Breast Cancer Foundation
J. Lohr Vineyards & Wines’ 10-year partnership with the National Breast Cancer Foundation (NBCF) ... -
Yeah, Doctor. I’m Talking to You
“Don’t eat or drink anything, because you might need a surgical procedure today,” my ... -
Planned Phase 2 Trial to Test Vaccine in Triple-negative Breast Cancer Patients, Generex Says
Generex Biotechnology has entered into an agreement with the NSABP Foundation to manage a possible ... -
2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment
The University of Hawaiʻi Cancer Center is enrolling participants in two clinical trials to test new ways ... -
Tecentriq-Chemo Combo Under FDA Review as First-line Therapy for PD-L1-positive, Metastatic Triple-negative Breast Cancer
The U.S. Food and Drug Administration (FDA) is reviewing Genentech’s request for Tecentriq (atezolizumab) to be ... -
We May Not Think About It, but Trusting the Process Is Important
Just before the plane took off, a weird noise punctured the air — a ... -
DoD Awards $11M for Phase 2 Trial of TPIV110 Breast Cancer Therapy
The U.S. Department of Defense (DoD) has awarded Mayo Clinic researchers $11 million to conduct ... -
Gary Buys a Sandwich
A baby carrot crossed my threshold. Let’s face it: Carrots aren’t supposed to look ... -
Early-stage Breast Cancer Patients Failing to Use to Hormone Therapy Long-term, French Study Finds
A high percentage of younger, premenopausal women being treated for early-stage breast cancer do ... -
Researchers Develop ‘Bio-patch’ to Monitor Post-surgical Success of Breast Reconstruction
An international team of researchers has developed a wireless device that can detect early ... -
Phase 2 Trial to Test Keytruda, Tomivosertib Combo in Triple-negative Breast Cancers
An upcoming Phase 2 trial will evaluate a combination of the immunotherapies Keytruda (pembrolizumab) ... -
The Dodgers, the Statue of Liberty, Breast Cancer, and Me
After the fifth inning, I found myself caught off guard. I’d just gone ... -
Ibrance-Faslodex Combo Improves Survival of Advanced Breast Cancer Patients, Phase 3 Trial Shows
Adding Pfizer’s Ibrance (palbociclib) to standard treatment Faslodex (fulvestrant) significantly extended the survival of advanced breast ...
Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU
News
The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more